Sg Americas Securities, LLC Eq Rx, Inc. Transaction History

Sg Americas Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$1.66 - $2.31 $256,523 - $356,968	154,532 Added 353.83%	198,206 $440,000
Q2 2023 Jul 10, 2023	SELL	$1.61 - $1.96 $40,547 - $49,362	-25,185 Reduced 36.57%	43,674 $81,000
Q1 2023 Apr 28, 2023	SELL	$1.8 - $2.83 $119,507 - $187,892	-66,393 Reduced 49.09%	68,859 $134,000
Q4 2022 Feb 02, 2023	BUY	$2.05 - $5.5 $216,662 - $581,289	105,689 Added 357.5%	135,252 $333,000
Q3 2022 Oct 31, 2022	SELL	$0.94 - $5.99 $51,579 - $328,683	-54,872 Reduced 64.99%	29,563 $146,000
Q2 2022 Jul 29, 2022	BUY	$3.2 - $5.69 $270,192 - $480,435	84,435 New	84,435 $396,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.